Nedaplatin or cisplatin given with chemotherapy for advanced non-small cell lung cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Sep 2014
Price : $35 *
At a glance
- Drugs Nedaplatin (Primary) ; Cisplatin
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Sep 2014 Status changed from unconfirmed to completed.
- 30 Jun 2014 New trial record
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.